Two new studies published in separate journals show that an experimental drug developed by Eli Lilly leads to meaningful weight loss.

One study, published in the Lancet and presented at the European Association for the Study of Diabetes, tested the drug retatrutide in people who were overweight or obese and had Type 2 diabetes: a population in which weight-loss medications have historically been less effective. People who took the highest dose lost about 18.8% of their starting body weight, while people who took a placebo lost 5.1%. About a third of the people in the study who took the highest dose of retatrutide lost at least 25% of their…

Read the full article at TIME.COM